Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.1.u1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 $ 661,103,391 $ 175,530 $ 775,241,114 $ (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Induced exercise of common warrants issued in offering (in shares)   4,517,427    
Induced exercise of common warrants issued in offering 3,613,941 $ 4,517 3,609,424  
Restricted stock vested (in shares)   659,479    
Restricted stock vested 0 $ 659 (659)  
Shares to cover tax withholding for restricted stock vested (in shares)   (79,634)    
Shares to cover tax withholdings for restricted stock vested 0 $ (79) 79  
Payments to cover tax withholdings for restricted stock vested, net (134,381)   (134,381)  
Share-based compensation 1,943,696   1,943,696  
Net income 32,715,779     32,715,779
Ending balance (in shares) at Mar. 31, 2023   180,627,484    
Ending balance at Mar. 31, 2023 699,242,426 $ 180,627 780,659,273 (81,597,474)
Beginning balance (in shares) at Dec. 31, 2023   196,837,001    
Beginning balance at Dec. 31, 2023 786,582,900 $ 196,837 795,834,675 (9,448,612)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   1,342,112    
Restricted stock vested 0 $ 1,342 (1,342)  
Shares to cover tax withholding for restricted stock vested (in shares)   (244,911)    
Shares to cover tax withholdings for restricted stock vested 0 $ (245) 245  
Payments to cover tax withholdings for restricted stock vested, net (814,985)   (814,985)  
Share-based compensation 1,723,832   1,723,832  
Net income 5,515,377     5,515,377
Ending balance (in shares) at Mar. 31, 2024   197,934,202    
Ending balance at Mar. 31, 2024 $ 793,007,124 $ 197,934 $ 796,742,425 $ (3,933,235)